0000899243-18-030608.txt : 20181210 0000899243-18-030608.hdr.sgml : 20181210 20181210211015 ACCESSION NUMBER: 0000899243-18-030608 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20181206 FILED AS OF DATE: 20181210 DATE AS OF CHANGE: 20181210 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: AZAB MOHAMMAD CENTRAL INDEX KEY: 0001309653 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36687 FILM NUMBER: 181227633 MAIL ADDRESS: STREET 1: C/O SUPERGEN, INC. STREET 2: 4140 DUBLIN BLVD., SUITE 200 CITY: DUBLIN STATE: CA ZIP: 94568 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Xenon Pharmaceuticals Inc. CENTRAL INDEX KEY: 0001582313 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 980661854 STATE OF INCORPORATION: A1 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 200 - 3650 GILMORE WAY CITY: BURNABY STATE: A1 ZIP: V5G 48W BUSINESS PHONE: (604) 484-3300 MAIL ADDRESS: STREET 1: 200 - 3650 GILMORE WAY CITY: BURNABY STATE: A1 ZIP: V5G 48W 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2018-12-06 0 0001582313 Xenon Pharmaceuticals Inc. XENE 0001309653 AZAB MOHAMMAD C/O XENON PHARMACEUTICALS INC 200 - 3650 GILMORE WAY BURNABY A1 V5G 4W8 BRITISH COLUMBIA, CANADA 1 0 0 0 Common Shares 2018-12-06 4 M 0 3086 3.07 A 57584 D Stock Option (Right to Buy) 3.07 2018-12-06 4 M 0 3086 0.00 D 2018-12-31 Common Shares 3086 0 D The exercise price was converted to U.S. dollars from $3.74 CAD using the closing rate of exchange on the Bank of Canada on the date of grant. The actual exercise price is the Canadian dollar amount regardless of the exchange rate on the day of exercise. The shares subject to the option fully vested on December 31, 2011. No shares were sold by the Reporting Person in connection with the exercise and the common shares issued as a result of the exercise are subject to the terms of a lock-up agreement executed by the Reporting Person in favor of the underwriters of the Company's public offering in September 2018. Exhibit 24 - Power of Attorney /s/ Valerie, Attorney-in-fact 2018-12-10 EX-24 2 attachment1.htm EX-24 DOCUMENT

                                POWER OF ATTORNEY

      The undersigned, as a Section 16 reporting person of Xenon Pharmaceuticals
 Inc. (the "Company"), hereby constitutes and appoints each of the responsible
attorneys and paralegals of Wilson Sonsini Goodrich & Rosati, Professional
Corporation, and each of Emmanuelle Vallee, Sherry Aulin and Valerie Holland of
the Company, the undersigned's true and lawful attorney-in-fact to:

      1. complete and execute Forms ID, 3,4 and 5 and other forms and all
         amendments thereto as such attorney-in-fact shall in his or her
         discretion determine to be required or advisable pursuant to Section
         16 of the Securities Exchange Act of 1934 (as amended) and the rules
         and regulations promulgated thereunder, or any successor laws and
         regulations, as a consequence of the undersigned's ownership,
         acquisition or disposition of securities of the Company; and

      2. do all acts necessary in order to file such forms with the Securities
         and Exchange Commission, any securities exchange or national
         association, the Company and such other person or agency as the
         attorney-in-fact shall deem appropriate.

      The undersigned hereby ratifies and confirms all that said attorneys-in-
fact and agents shall do or cause to be done by virtue hereof.  The undersigned
acknowledges that the foregoing attorneys-in-fact, in serving in such capacity
at the request of the undersigned, are not assuming, nor is the Company
assuming, any of the undersigned's responsibilities to comply with Section 16 of
the Securities Exchange Act of 1934 (as amended).

      This Power of Attorney shall remain in full force and effect until the
undersigned is no longer required to file Forms ID, 3, 4 and 5 with respect to
the undersigned's holdings of and transactions in securities issued by the
Company, unless earlier revoked by the undersigned in a signed writing delivered
to the Company and the foregoing attorneys-in-fact.

      IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to
be executed as of this 10th day of December, 2018.




                                    Signature:     /s/ Mohammed Azab
                                               --------------------------------
                                               Mohammad Azab